| Literature DB >> 29261806 |
Jeremías Enrique Zubrzycki1, Carla Andrea Maringolo2, Carla Valeria Filippi1,3, Facundo José Quiróz2, Verónica Nishinakamasu1, Andrea Fabiana Puebla1, Julio A Di Rienzo4, Alberto Escande2, Verónica Viviana Lia1,3,5, Ruth Amalia Heinz1,3,5, Horacio Esteban Hopp1,5, Gerardo D L Cervigni3,6, Norma Beatriz Paniego1,3.
Abstract
Sclerotinia Head Rot (SHR), a disease caused by Sclerotinia sclerotiorum, is one of the most limiting factors in sunflower production. In this study, we identified genomic loci associated with resistance to SHR to support the development of assisted breeding strategies. We genotyped 114 Recombinant Inbred Lines (RILs) along with their parental lines (PAC2 -partially resistant-and RHA266 -susceptible-) by using a 384 single nucleotide polymorphism (SNP) Illumina Oligo Pool Assay to saturate a sunflower genetic map. Subsequently, we tested these lines for SHR resistance using assisted inoculations with S. sclerotiorum ascospores. We also conducted a randomized complete-block assays with three replicates to visually score disease incidence (DI), disease severity (DS), disease intensity (DInt) and incubation period (IP) through four field trials (2010-2014). We finally assessed main effect quantitative trait loci (M-QTLs) and epistatic QTLs (E-QTLs) by composite interval mapping (CIM) and mixed-model-based composite interval mapping (MCIM), respectively. As a result of this study, the improved map incorporates 61 new SNPs over candidate genes. We detected a broad range of narrow sense heritability (h2) values (1.86-59.9%) as well as 36 M-QTLs and 13 E-QTLs along 14 linkage groups (LGs). On LG1, LG10, and LG15, we repeatedly detected QTLs across field trials; which emphasizes their putative effectiveness against SHR. In all selected variables, most of the identified QTLs showed high determination coefficients, associated with moderate to high heritability values. Using markers shared with previous Sclerotinia resistance studies, we compared the QTL locations in LG1, LG2, LG8, LG10, LG11, LG15 and LG16. This study constitutes the largest report of QTLs for SHR resistance in sunflower. Further studies focusing on the regions in LG1, LG10, and LG15 harboring the detected QTLs are necessary to identify causal alleles and contribute to unraveling the complex genetic basis governing the resistance.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29261806 PMCID: PMC5738076 DOI: 10.1371/journal.pone.0189859
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Statistical analysis for four disease resistant traits of RIL population and parents in multiple environments.
| Trait | Field Trial ID | Biparental Mapping Population | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Min | Max | Mean | SD | Skewness | Kurtosis | CV (%) | |||
| FT1 | 0.00 | 1.00 | 0.51 ± 0.02 | 0.27 | -0.17 | -0.95 | 52.95 | 45.61 | |
| FT2 | 0.00 | 0.75 | 0.11 ± 0.01 | 0.18 | 1.78 | 2.26 | 161.56 | 7.34 | |
| FT3 | 0.00 | 1.00 | 0.65 ± 0.02 | 0.25 | -0.54 | -0.24 | 37.97 | 34.98 | |
| FT4 | 0.00 | 1.00 | 0.48 ± 0.02 | 0.29 | 0.09 | -0.99 | 60.14 | 31.49 | |
| AFT | 0.00 | 1.00 | 0.45 ± 0.01 | 0.32 | 0.01 | -1.23 | 70.67 | N/A | |
| FT1 | 0.01 | 1.00 | 0.18 ± 0.01 | 0.14 | 3.18 | 13.52 | 79.40 | 20.40 | |
| FT2 | 0.01 | 1.00 | 0.30 ± 0.03 | 0.27 | 0.90 | -0.10 | 92.76 | 43.36 | |
| FT3 | 0.01 | 1.00 | 0.51 ± 0.01 | 0.21 | 0.04 | -0.23 | 41.08 | 20.49 | |
| FT4 | 0.01 | 0.80 | 0.29 ± 0.02 | 0.18 | 0.27 | -0.56 | 62.04 | 50.52 | |
| AFT | 0.01 | 1.00 | 0.35 ± 0.01 | 0.24 | 0.59 | -0.37 | 68.64 | N/A | |
| FT1 | 0.00 | 0.36 | 0.04 ± 0.0038 | 0.05 | 3.90 | 20.14 | 131.87 | 1.86 | |
| FT2 | 0.00 | 0.36 | 0.03 ± 0.0044 | 0.06 | 3.01 | 9.93 | 220.20 | 2.87 | |
| FT3 | 0.00 | 0.88 | 0.28 ± 0.01 | 0.19 | 0.60 | -0.31 | 67.99 | 26.49 | |
| FT4 | 0.00 | 0.70 | 0.12 ± 0.01 | 0.14 | 1.41 | 1.75 | 112.52 | 59.90 | |
| AFT | 0.00 | 0.88 | 0.13 ± 0.01 | 0.17 | 1.56 | 1.89 | 130.24 | N/A | |
| FT1 | 16.00 | 42.00 | 27.91 ± 0.31 | 4.43 | -0.01 | 0.02 | 15.88 | 13.74 | |
| FT2 | 14.00 | 28.00 | 20.26 ± 0.41 | 3.56 | 0.39 | -0.51 | 17.57 | 45.48 | |
| FT3 | 14.00 | 28.00 | 19.49 ± 0.19 | 2.75 | 0.32 | -0.24 | 14.08 | 37.94 | |
| FT4 | 14.00 | 28.00 | 20.91 ± 0.25 | 2.86 | -0.12 | -0.48 | 13.67 | 52.45 | |
| AFT | 14.00 | 42.00 | 22.63 ± 0.20 | 5.13 | 0.77 | 0.16 | 22.66 | N/A | |
aField Trial ID FT1-4 and AFT represent: Balcarce October 2009; Balcarce December 2011; Balcarce December 2012; Balcarce December 2013; Across Field Trials, respectively.
DI = Disease Incidence
DS = Disease Severity
DInt = Disease Intensity
IP = Incubation Period
SD = Standard Deviation
CV = Coefficient of variation
N/A = not assigned
Fig 1Genetic linkage map of BMP showing locations on LG1-5 of different types of QTLs and interactions detected through single- and two-locus QTL analyses for resistance traits.
Mapped markers are listed on the left. Underlined markers correspond to the 61 SNPs mapped in this work. Lengths of confidence Interval (CI) for the M-QTL and the Ep-QTL are denoted by full lines and dashed lines, respectively. Epistatic interaction between QTLs is represented with arrows. SHR QTLs coincident with previous reported QTLs are in bold. *QTLs detected using QTL Cartographer. **QTLs detected using QTLNetwork. ***QTLs detected using both programs.
Fig 4Genetic linkage map of BMP showing locations on LG14-17 of different types of QTLs and interactions detected through single- and two-locus QTL analyses for resistance traits.
Mapped markers are listed on the left. Underlined markers correspond to the 61 SNPs mapped in this work. Lengths of confidence Interval (CI) for the M-QTL and the Ep-QTL are denoted by full lines and dashed lines, respectively. Epistatic interaction between QTLs is represented with arrows. SHR QTLs coincident with previous reported QTLs are in bold. * QTLs detected using QTL Cartographer. ** QTLs detected using QTLNetwork. *** QTLs detected using both programs.
Marker density and marker distribution on sunflower linkage groups (LGs).
| LG | # AFLP | # SSR | # EST-SSR | # InDel | # SNP | # HeAn | # | Length (cM) | Density (cM/ |
|---|---|---|---|---|---|---|---|---|---|
| 15 | 8 | - | - | - | 3 | 26 | 120.34 | 4.63 | |
| 16 | 14 | - | - | - | 7 | 37 | 157.11 | 4.25 | |
| 19 | 13 | - | - | - | 3 | 35 | 143.77 | 4.11 | |
| 20 | 7 | 2 | - | - | 1 | 30 | 143.50 | 4.78 | |
| 16 | 12 | - | - | - | 4 | 32 | 176.26 | 5.51 | |
| 15 | 7 | - | - | 2 | 2 | 26 | 125.55 | 4.83 | |
| 16 | 8 | - | - | - | 1 | 25 | 103.15 | 4.13 | |
| 19 | 20 | 1 | - | - | 3 | 43 | 183.59 | 4.27 | |
| 27 | 18 | - | - | 1 | 4 | 50 | 239.35 | 4.79 | |
| 50 | 20 | 1 | 1 | 2 | 7 | 81 | 276.64 | 3.42 | |
| 14 | 7 | - | - | 1 | 4 | 26 | 107.86 | 4.15 | |
| 17 | 17 | - | - | 1 | 5 | 40 | 178.00 | 4.45 | |
| 9 | 6 | - | - | 1 | - | 16 | 88.31 | 5.52 | |
| 19 | 19 | - | 1 | - | 7 | 46 | 181.63 | 3.95 | |
| 11 | 14 | 1 | - | - | 4 | 30 | 113.79 | 3.79 | |
| 21 | 26 | 2 | - | - | 5 | 54 | 214.61 | 3.97 | |
| 23 | 13 | 1 | - | - | 1 | 38 | 270.34 | 7.11 | |
| 327 | 229 | 8 | 2 | 8 | 61 | 635 | 2,823.80 | - | |
| 19.24 | 13.47 | 0.47 | 0.12 | 0.47 | 3.59 | 37.35 | 166.11 | 4.45 |
aSNPs previously mapped [25,44–45]
bHeAn-SNPs identified and mapped in this work.
Parameters associated with main effect QTLs detected in BMP by single-locus analysis using QTL Cartographer.
| Trait | QTL | Field Trial | LG | Marker | Position on LG (cM) | LOD score | Additive effect (a) | % Phenotypic Variation Explained ( | Confidence interval (cM) | Parental contribution |
|---|---|---|---|---|---|---|---|---|---|---|
| FT3 | 1 | E40M62_4 | 48.60 | 3.71 | 0.08 | 13.61 | 8.30 | N/A | ||
| FT2 | 1 | HeAn_C_10493.1 | 96.70 | 4.30 | -0.04 | 15.15 | 3.30 | PR | ||
| FT1 | 7 | ORS1041 | 42.10 | 3.70 | 0.09 | 12.45 | 12.20 | PS | ||
| AFT | 13 | E33M48_20 | 27.50 | 4.43 | 0.08 | 15.94 | 9.70 | N/A | ||
| FT3 | 14 | ORS301 | 143.40 | 4.11 | -0.04 | 16.06 | 4.20 | PR | ||
| AFT | 15 | HeAn_R_534.1 | 80.20 | 7.25 | -0.09 | 22.63 | 4.50 | PR | ||
| FT3 | 15 | HeAn_C_12025.1/HeAn_C_11434.1 | 85.00 | 6.15 | -0.10 | 19.77 | 4.00 | PR | ||
| FT4 | 15 | ORS1242 | 87-0 | 4.10 | -0.10 | 14.71 | 3.30 | PR | ||
| AFT | 15 | ORS687 | 90.80 | 6.87 | -0.09 | 23.87 | 4.50 | PR | ||
| FT1 | 1 | E37M47_15 | 35.40 | 5.36 | -0.04 | 24.92 | 2.20 | N/A | ||
| FT2 | 1 | HeAn_C_8647.2 | 99.30 | 5.67 | -0.19 | 29.12 | 11.00 | PR | ||
| FT2 | 1 | HA77 | 104.80 | 4.63 | -0.19 | 28.10 | 11.00 | PR | ||
| AFT | 2 | E40M62_17 | 102.80 | 3.41 | -0.05 | 12.05 | 7.70 | N/A | ||
| FT4 | 9 | E38M48_5 | 164.40 | 4.86 | -0.07 | 20.84 | 2.30 | N/A | ||
| AFT | 10 | ORS591 | 124.40 | 4.57 | -0.06 | 16.97 | 6.60 | PR | ||
| FT3 | 10 | E41M50_3 | 150.40 | 4.22 | -0.08 | 16.20 | 0.70 | N/A | ||
| FT2 | 10 | GLP_4 | 271.10 | 4.94 | 0.16 | 29.65 | 6.00 | PS NS | ||
| FT1 | 16 | HA4222 | 142.10 | 3.44 | 0.04 | 13.90 | 5.40 | PS | ||
| FT2 | 1 | HeAn_C_8647.2 | 98.70 | 4.25 | -0.02 | 15.65 | 11.90 | PR | ||
| FT2 | 1 | ORS662 | 106.80 | 4.52 | -0.02 | 18.66 | 11.90 | PR | ||
| FT3 | 8 | E37M61_7 | 54.50 | 4.00 | -0.06 | 16.17 | 10.70 | N/A | ||
| FT4 | 8 | HA3278 | 167.70 | 3.78 | -0.05 | 14.76 | 13.20 | PR | ||
| FT3 | 10 | E32M61_7 | 76.10 | 4.27 | -0.07 | 20.14 | 10.80 | N/A | ||
| AFT | 10 | SSL39 | 121.80 | 3.81 | -0.03 | 14.87 | 3.00 | PR | ||
| FT1 | 11 | E32M49_2 | 41.30 | 3.73 | 0.02 | 15.23 | 2.50 | N/A | ||
| FT1 | 11 | E35M48_3 | 54.80 | 4.25 | -0.02 | 17.38 | 2.00 | N/A | ||
| FT1 | 12 | E33M48_22 | 103.00 | 6.13 | 0.02 | 23.45 | 5.20 | N/A | ||
| FT2 | 13 | E33M48_20 | 24.30 | 4.71 | 0.02 | 20.50 | 10.70 | N/A | ||
| FT1 | 15 | SSU25 | 24.60 | 3.08 | -0.01 | 12.05 | 4.80 | PR NS | ||
| FT1 | 15 | ORS401 | 46.50 | 5.33 | 0.02 | 23.05 | 6.80 | PS | ||
| AFT | 1 | HA77 | 102.30 | 7.35 | 1.25 | 29.05 | 2.10 | PR | ||
| FT3 | 2 | E41M62_28 | 17.90 | 4.64 | -1.17 | 17.39 | 6.50 | N/A | ||
| FT1 | 3 | HeAn_R_283.1 | 123.70 | 4.23 | 1.27 | 16.76 | 7.50 | PR | ||
| FT2 | 8 | HA911 | 50.00 | 4.26 | 1.86 | 21.92 | 5.10 | PR | ||
| FT4 | 12 | E33M48_22 | 105.00 | 3.65 | -1.02 | 14.94 | 10.90 | N/A | ||
| AFT | 15 | HA4239 | 71.70 | 4.26 | 1.02 | 19.95 | 11.60 | PR | ||
| FT4 | 15 | E38M48_4 | 99.40 | 5.35 | 1.17 | 20.70 | 3.00 | N/A | ||
| AFT | 16 | ORS788 | 157.70 | 4.37 | 0.92 | 15.61 | 4.70 | PR | ||
| FT1 | 17 | E41M62_19 | 201.00 | 4.59 | 1.55 | 24.15 | 6.00 | N/A |
aFT1 = Balcarce October 2009, FT2 = Balcarce December 2011, FT3 = Balcarce December 2012, FT4 = Balcarce December 2013, AFT = across field trials, pooled data from all the trials.
bMarker defining QTL, closer to the highest LOD value.
cQTL detected by both QTL Cartographer and QTLNetwork.
DI = Disease Incidence
DS = Disease Severity
DInt = Disease Intensity
IP = Incubation Period
N/A = not assigned
Parameters associated with main-effect QTLs and those involved in interaction with the trial (environment) detected in BMP by two-locus analysis using QTLNetwork.
| Trait | QTL | LG | Marker | Position on LG (cM) | Confidence interval (cM) | Additive effect (a) | QTL × Environment interactions | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Field Trial | Additive effects (ae) | |||||||||
| 15 | HeAn_R_534.1 | 80.70 | 8.00 | -0.08 | 15.32 | - | - | - | ||
| 1 | HeAn_C_8647.2 | 99.30 | 2.60 | -0.06 | 7.43 | FT1, FT2 | -0.09 to 0.05 | 1.22 to 4.63 | ||
| 10 | E40M50_16 | 214.30 | 4.50 | -0.01 | 0.08 | FT2, FT3 | -0.04 to 0.06 | 1.22 to 2.81 | ||
| 10 | E41M50_3 | 150.30 | 1.90 | -0.03 | 6.20 | FT1, FT2, FT3 | -0.03 to 0.02 | 1.56 to 2.22 | ||
| 8 | HA911 | 51.90 | 8.60 | 0.88 | 9.81 | - | - | - | ||
aMarker defining QTL, closer to the highest LOD value.
bPercentages of the phenotypic variations explained by additive effects.
cField trial in which Q × E was detected for the particular QTL. FT1 = Balcarce October 2009, FT2 = Balcarce December 2011, FT3 = Balcarce December 2012, FT4 = Balcarce December 2013, AFT = across field trials, pooled data from all the trials.
dPercentage of the phenotypic variations explained by the additive effect of the QTL × environment interaction.
eQTL detected by both QTL Cartographer and QTLNetwork.
DI = Disease Incidence
DS = Disease Severity
DInt = Disease Intensity
IP = Incubation Period
Parameters associated with epistatic QTLs involved in additive-by-additive interactions detected in BMP using QTLNetwork.
| Trait | QTL | LG | Marker | Position on LG (cM) | Confidence interval (cM) | QTL | LG | Marker | Position on LG (cM) | Confidence interval (cM) | aa | h2aa (%) | QTL × QTL × Environment interactions | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Field Trial | aae | h2aae (%) | |||||||||||||
| 8 | ORS894_2 | 173.00 | 4.80 | 10 | E33M60_2 | 204.50 | 4.80 | -0.02 | 0.72 | - | - | - | |||
| 2 | HeAn_R_174.1 | 35.50 | 6.90 | 15 | E38M48_4 | 99.40 | 4.20 | 0.04 | 2.29 | FT2, FT3 | -0.04 to 0.06 | 1.15 to 3.26 | |||
| 7 | E32M49_11 | 79.60 | 4.70 | 9 | E33M60_5 | 156.80 | 4.60 | 0.05 | 4.57 | FT2 | 0.05 | 2.16 | |||
| 7 | E40M62_21 | 87.90 | 3.00 | 11 | HeAn_C_5453.1 | 24.50 | 6.00 | 0.04 | 3.18 | - | - | - | |||
| 3 | HA1770 | 121.90 | 7.50 | 17 | SSL87 | 48.60 | 11.60 | 0.04 | 9.80 | - | - | - | |||
| 16 | HeAn_R_126.2 | 13.10 | 3.40 | 17 | E38M50_21 | 113.50 | 8.30 | 0.46 | 6.25 | - | - | - | |||
| 16 | HeAn_R_126.2 | 13.10 | 3.40 | 17 | TC26323 | 130.30 | 8.00 | 0.45 | 4.69 | FT2 | -0.80 | 1.94 | |||
aMarker defining QTL, closer to the highest LOD value.
bAdditive by additive interaction between loci i and j.
cPercentages of the phenotypic variations explained by additive by additive interactions.
dField Trial = Field trial in which Q × E was detected for the particular QTL. FT1 = Balcarce October 2009, FT2 = Balcarce December 2011, FT3 = Balcarce December 2012, FT4 = Balcarce December 2013, AFT = across field trials, pooled data from all the trials.
eEffect of the epistasis × environment interactions.
fPercentage of the phenotypic variations explained by the epistasis × environment interactions.
DI = Disease Incidence
DS = Disease Severity
DInt = Disease Intensity
IP = Incubation Period